Study guide

20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

Key Takeaways Explain This Topic AI

Surgical airway fires require the classic triad of Fuel, Oxidizer, and Ignition Source; during airway laser surgery, oxidizers must be minimized (FiO₂ ≤ 30%, avoid N₂O entirely), laser-safe dual-cuffed ETTs must be used with saline/methylene blue cuff inflation, and immediate fire response mandates extubating the burning tube, extinguishing with saline, and discontinuing gas flows.

Post-tonsillectomy bleeding is a critical pediatric emergency presenting with hidden hypovolemia and a stomach filled with swallowed blood; management requires aggressive intravenous volume resuscitation before induction, two functional suction setups, and a rapid sequence induction (RSI) followed by mandatory stomach evacuation.

Tumescent liposuction utilizes dilute lidocaine (0.05-0.1%) with epinephrine up to maximum doses of 35 to 55 mg/kg; intense local vasoconstriction delays peak plasma lidocaine concentrations to 12 to 14 hours postoperatively, mandating extended surveillance for Local Anesthetic Systemic Toxicity (LAST).

Trauma resuscitation adheres to Damage Control principles (1:1:1 balanced transfusion of PRBCs, FFP, platelets; early Tranexamic Acid within 3 hours; permissive hypotension SBP 80-90 mmHg); however, permissive hypotension is STRICTLY CONTRAINDICATED in Traumatic Brain Injury (TBI), where avoiding hypotension (SBP <90 mmHg) and hypoxia (PaO₂ <60 mmHg) is paramount.

Major burn resuscitation utilizes the Parkland formula (4 mL × kg × %TBSA in 24h: 50% in the first 8h from injury, 50% in the remaining 16h; target UOP 0.5-1.0 mL/kg/hr); Succinylcholine is safe in the first 24-48 hours but is STRICTLY CONTRAINDICATED after 24-48 hours for 1-2 years due to extrajunctional receptor upregulation and lethal hyperkalemic cardiac arrest.

Last updated: August 2026

20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

Shared airway surgery, complex extrathoracic procedures, and emergency trauma/burn resuscitation require rapid clinical decision-making, specialized equipment mastery, and precise pharmacological knowledge. Anesthesia providers must effectively prevent and manage intraoperative airway fires, stabilize the bleeding pediatric tonsil, surveil delayed toxicity from tumescent local anesthetics, optimize cerebral perfusion during damage control trauma resuscitation, and navigate altered neuromuscular pharmacology in thermal burn injury.

1. ENT Shared Airway & Laser Surgery Fire Safety

Surgical procedures involving the larynx, vocal cords, or trachea frequently utilize surgical lasers (CO₂, Nd:YAG, KTP) within a shared airway environment. This creates a high-risk environment for operating room airway fires . +---------------------------------------------------------------------------------------------------------+

  • | THE SURGICAL FIRE TRIAD |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Triad Component | Operative Source | Anesthetic Prevention Strategies |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **1. Oxidizer** | • Oxygen (O₂)
  • Nitrous Oxide (N₂O) | • Maintain **FiO₂ ≤ 0.30 (30%)** with air|
  • | | (N₂O supports combustion identically| • **STRICTLY AVOID N₂O** in laser surgery|
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **2. Fuel** | • Endotracheal tube (PVC, silicone) | • Use **Laser-Safe Metal/Foil-Wrapped ETT|
  • | | • Drapes, sponges, surgical prep | • Wet cotton pledges/sponges in pharynx |
  • | | • Tracheal tissue / hair / fat | • Dry alcohol-based preps ≥ 3 minutes |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **3. Ignition Source**| • Surgical Laser (CO₂, Nd:YAG, KTP) | • Place laser in **STANDBY mode** when not|
  • | | • Electrocautery (Bovie) | actively in the surgeon's hands |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • Laser-Safe Endotracheal Tubes & Dual-Cuff Protocol

Standard PVC Tubes: Highly flammable; laser strike immediately ignites PVC, producing a blowtorch effect that releases toxic hydrogen chloride gas into the bronchial tree. Standard PVC tubes are strictly prohibited during laser airway surgery.

Specialized Laser Tubes: Constructed of flexible stainless steel (e.g., Laser-Flex) or silicone wrapped in copper/aluminum foil with an outer Teflon coating.

Dual-Cuff Management: Laser-safe tubes feature two separate cuffs (proximal and distal). Both cuffs are inflated with sterile saline tinted with methylene blue :

The saline acts as a physical heat sink/flame retardant.

If the laser accidentally strikes the proximal cuff, the blue saline leaks, immediately alerting the team to cuff puncture while quenching potential sparks; the intact distal cuff continues to protect the lower airway from aspiration and maintain positive pressure ventilation. [IMMEDIATE AIRWAY FIRE EMERGENCY PROTOCOL]

  • [STEP 1: SIMULTANEOUS ACTION - HALT & EXTUBATE]
  • **IMMEDIATELY EXTUBATE the burning endotracheal tube**
  • **HALT all ventilation & STOP gas flow**
  • Remove all burning sponges/drapes from airway
  • |
  • v
  • [STEP 2: EXTINGUISH BURNING TISSUES]
  • **Pour sterile saline or sterile water directly into airway**
  • |
  • v
  • [STEP 3: ISOLATE OXIDIZERS]
  • Turn off oxygen and gas flows at machine/wall
  • |
  • v
  • [STEP 4: RESTORE VENTILATION]
  • Resume mask ventilation with **100% O₂** (or air)
  • Avoid flammable materials; re-intubate with standard ETT
  • |
  • v
  • [STEP 5: ASSESS DAMAGE & MONITOR]
  • Perform **Rigid/Flexible Bronchoscopy** to inspect tracheobronchial
  • tree, remove soot, foreign bodies, and debris
  • Administer humidified O₂, steroids, and monitor in ICU for ARDS
  • 2. Post-Tonsillectomy Hemorrhage: The "Bleeding Tonsil"

Post-tonsillectomy hemorrhage is a life-threatening pediatric emergency occurring in up to 2 − 5 % 2 - 5\% 2 − 5% of patients, with a bimodal distribution: Primary hemorrhage ( < 24 hours <24 \text{ hours} < 24 hours postop, usually due to surgical ligature slippage) and Secondary hemorrhage (Postoperative Days 5 − 10 5 - 10 5 − 10 , due to premature sloughing of the eschar/scab). +---------------------------------------------------------------------------------------------------------+

  • | THE BLEEDING TONSIL CLINICAL TRIAD |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Component | Pathophysiologic Mechanism | Clinical Anesthetic Danger |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **1. Hypovolemia** | • Continuous slow venous or arterial | • **Severe unappreciated hypovolemic |
  • | | ooze; child swallows blood quietly | shock** unmasked by induction agents |
  • | | • Tachycardia, orthostasis, pale/cool| • Hypotension is a late, pre-terminal sign|
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **2. Full Stomach** | • Stomach filled with swallowed clots| • **Extreme aspiration risk** on induc- |
  • | | and active liquid blood | tion and emergence |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **3. Difficult Air-** | • Active pharyngeal bleeding obscures| • Inability to visualize vocal cords; |
  • | ** way / Vision** | glottic structures and cord anatomy| equipment clogs with thick blood clots |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • Anesthetic Management Plan for Bleeding Tonsil

Resuscitation BEFORE Induction: Never induce a bleeding tonsil patient without restoring intravascular volume. Establish two large-bore IVs , draw type and crossmatch, and infuse warm crystalloid or uncrossmatched/type-specific blood until volume deficits are corrected (normalize heart rate and capillary refill).

Airway Setup: Prepare TWO fully functional suction setups with rigid Yankauer tips connected to distinct vacuum canisters. Have multiple video laryngoscope and direct laryngoscope blades ready, along with a styletted ETT and a smaller size (downsized by 0.5-1.0 mm).

Induction: Perform a Rapid Sequence Induction (RSI) with cricoid pressure. Position patient in slight Trendelenburg or left tilt to allow blood to pool in the upper pharynx away from the laryngeal inlet.

Gastric Evacuation: Following successful tracheal intubation, pass a large-bore orogastric tube (Ewald or 18 Fr OG tube) under direct visualization to aggressively decompress and evacuate swallowed blood clots from the stomach. This prevents postoperative vomiting, aspiration, and severe nausea.

Extubation: The patient MUST be extubated fully awake, responsive, with return of intact airway protective reflexes , positioned in the lateral "tonsil position" (recovery position).

3. Tumescent Liposuction & Delayed LAST

Tumescent liposuction involves subcutaneous infiltration of large volumes of crystalloid containing dilute local anesthetic and epinephrine into adipose tissue prior to suction aspiration. +---------------------------------------------------------------------------------------------------------+

  • | TUMESCENT ANESTHESIA SOLUTION FORMULATION |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Component | Typical Concentration | Pharmacologic Function |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Dilute Lidocaine** | **0.05% - 0.1%** (500 - 1000 mg/L) | • Local anesthesia across surgical field |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Epinephrine** | **1:1,000,000** (1 mg/L) | • Intense subcutaneous vasoconstriction; |
  • | | | minimizes surgical blood loss (<1%) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Sodium Bicarbonate**| **10 mEq / L** | • Neutralizes acidity; speeds onset and |
  • | | | dramatically reduces injection pain |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Carrier Fluid** | 0.9% Normal Saline or Lactated Ringer| • Tumescence and tissue expansion |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • Maximum Dosing & Unique Pharmacokinetics

Standard Max Lidocaine Dose: 4.5 mg/kg 4.5 \text{ mg/kg} 4.5 mg/kg plain, or 7.0 mg/kg 7.0 \text{ mg/kg} 7.0 mg/kg with epinephrine.

Tumescent Max Lidocaine Dose: Up to 35 − 55 mg/kg 35 - 55 \text{ mg/kg} 35 − 55 mg/kg .

Mechanism of Safety: Intense epinephrine-mediated vasoconstriction, high lipid solubility of lidocaine in avascular adipose tissue, and mechanical removal of a portion of the injected drug during aspiration slow systemic vascular absorption.

The 12-to-14-Hour Delayed Peak: Unlike standard peripheral nerve blocks (where peak plasma levels occur in 15 − 45 minutes 15 - 45 \text{ minutes} 15 − 45 minutes delays), peak plasma lidocaine concentrations following tumescent infiltration occur 12 to 14 hours 12 \text{ to } 14 \text{ hours} 12 to 14 hours post-infiltration (range: 8 − 16 hours 8 - 16 \text{ hours} 8 − 16 hours ) .

Clinical Warning: Patients discharged home on the afternoon of surgery may develop life-threatening Local Anesthetic Systemic Toxicity (LAST) late at night or the following morning. Educate patients and families on symptoms of LAST (perioral numbness, tinnitus, metallic taste, visual changes, muscle twitches, seizures, cardiovascular collapse). If LAST occurs, immediately administer 20% Lipid Emulsion (1.5 mL/kg bolus over 1 min, then 0.25 mL/kg/min infusion) .

4. Trauma Resuscitation: Damage Control vs. Traumatic Brain Injury +---------------------------------------------------------------------------------------------------------+

  • | THE TRAUMA LETHAL DIAMOND |
  • +---------------------------------------------------------------------------------------------------------+
  • | 1. **Hypothermia** (<35°C) → Impairs coagulation enzyme kinetics & platelet function |
  • | 2. **Coagulopathy** (Trauma-ind)→ Consumption of clotting factors & accelerated fibrinolysis |
  • | 3. **Acidosis** (pH < 7.20) → Drastically reduces thrombin generation & myocardial contractility |
  • | 4. **Hypocalcemia** (iCa < 1.1) → Citrate toxicity from PRBCs; impairs clotting cascade & vascular tone|
  • +---------------------------------------------------------------------------------------------------------+
  • Damage Control Resuscitation (DCR) in Non-Head Injured Trauma

Balanced Hemostatic Transfusion: Early administration of packed red blood cells (PRBCs), fresh frozen plasma (FFP), and platelets in a 1 : 1 : 1 1:1:1 1 : 1 : 1 ratio to prevent dilution of clotting factors and thrombocytopenia.

Early Tranexamic Acid (TXA): Administer 1 g IV 1 \text{ g IV} 1 g IV over 10 minutes within 3 hours of injury (CRASH-2 trial), followed by 1 g 1 \text{ g} 1 g infused over 8 hours to halt hyperfibrinolysis.

Permissive Hypotension: Maintain a systolic blood pressure of 80 − 90 mmHg 80 - 90 \text{ mmHg} 80 − 90 mmHg (MAP 50 − 60 mmHg 50 - 60 \text{ mmHg} 50 − 60 mmHg ) until surgical or angiographic hemostasis is achieved. This prevents "popping the clot" and dislodging fragile early platelet plugs.

The Inviolable Exception: Traumatic Brain Injury (TBI)

NCE Clinical Rule — TBI Hemodynamic Targets: Permissive hypotension is STRICTLY CONTRAINDICATED in the presence of Traumatic Brain Injury (TBI) or spinal cord trauma. A single episode of systolic hypotension ( S B P < 90 mmHg SBP < 90 \text{ mmHg} SBP < 90 mmHg ) or arterial hypoxemia ( P a O 2 < 60 mmHg PaO_2 < 60 \text{ mmHg} P a O 2 ​ < 60 mmHg or S p O 2 < 90 % SpO_2 < 90\% Sp O 2 ​ < 90% ) doubles mortality in head-injured patients. +---------------------------------------------------------------------------------------------------------+

  • | RESUSCITATION TARGET COMPARISON MATRIX |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Resuscitation Target | Non-TBI Hemorrhagic Trauma (DCR) | Polytrauma with Traumatic Brain Injury |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Systolic BP (SBP)** | **80 - 90 mmHg** (Permissive Hypo) | **≥ 100 - 110 mmHg** (AVOID SBP <90!) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Mean Arterial Press**| **50 - 60 mmHg** | **≥ 80 mmHg** |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **CPP Target** | N/A | **60 - 70 mmHg** |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Ventilation Target**| Normocarbia | **Normocarbia (PaCO₂ 35 - 40 mmHg)** |
  • | | | Prophylactic hyperventilation is HARMFUL |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Airway Precautions**| Standard RSI | **Manual In-Line Stabilization (MILS)** |
  • | | | Avoid neck extension (protect C-spine) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • 5. Major Burn Resuscitation: The Parkland Formula

Thermal burn injuries covering ≥ 20 % \ge 20\% ≥ 20% of Total Body Surface Area (TBSA) precipitate massive systemic capillary leak, hypovolemic-distributive burn shock, and profound metabolic alterations. [THE RULE OF NINES FOR ADULT BURN TBSA]

  • [Head & Neck] = 9%
  • [Anterior Torso] = 18% [Posterior Torso] = 18%
  • [Each Arm (x2)] = 9% each (18% total)
  • [Each Leg (x2)] = 18% each (36% total)
  • [Perineum / Genitalia] = 1%
  • ----------------------------------------
  • Total Body Surface Area = 100%

The Parkland (Baxter) Fluid Formula Total 24-Hour Crystalloid (Lactated Ringer’s) = 4 mL × Weight (kg) × % TBSA (2nd and 3rd degree burns) \text{Total 24-Hour Crystalloid (Lactated Ringer's)} = 4 \text{ mL} \times \text{Weight (kg)} \times \% \text{TBSA (2nd and 3rd degree burns)} Total 24-Hour Crystalloid (Lactated Ringer’s) = 4 mL × Weight (kg) × % TBSA (2nd and 3rd degree burns) +-------------------------------------------------------------------------+

  • | PARKLAND RESUSCITATION TIME TIMELINE |
  • +-------------------------------------------------------------------------+
  • | • FIRST 8 HOURS (FROM TIME OF INJURY): |
  • | Administer **50% of the total calculated 24-hour volume** |
  • | *Caution:* Clock starts at the **MOMENT OF BURN**, NOT hospital arrival|
  • | |
  • | • REMAINING 16 HOURS: |
  • | Administer the remaining **50% of the calculated volume** |
  • +-------------------------------------------------------------------------+

Calculation Example: An 80 kg adult with a 40% TBSA burn:

Total 24-hr Fluid = 4 mL × 80 kg × 40 = 12 , 800 mL (12.8 L of LR) \text{Total 24-hr Fluid} = 4 \text{ mL} \times 80 \text{ kg} \times 40 = 12,800 \text{ mL} \text{ (12.8 L of LR)} Total 24-hr Fluid = 4 mL × 80 kg × 40 = 12 , 800 mL (12.8 L of LR)

First 8 hours: 12 , 800 × 0.5 = 6 , 400 mL 12,800 \times 0.5 = 6,400 \text{ mL} 12 , 800 × 0.5 = 6 , 400 mL ( 800 mL/hr 800 \text{ mL/hr} 800 mL/hr )

Next 16 hours: 12 , 800 × 0.5 = 6 , 400 mL 12,800 \times 0.5 = 6,400 \text{ mL} 12 , 800 × 0.5 = 6 , 400 mL ( 400 mL/hr 400 \text{ mL/hr} 400 mL/hr )

Resuscitation Endpoint: Titrate fluid rates to maintain adult Urine Output at 0.5 − 1.0 mL/kg/hr 0.5 - 1.0 \text{ mL/kg/hr} 0.5 − 1.0 mL/kg/hr ( 1.0 − 2.0 mL/kg/hr 1.0 - 2.0 \text{ mL/kg/hr} 1.0 − 2.0 mL/kg/hr in children under 30 kg). Avoid "fluid creep" and over-resuscitation, which cause abdominal compartment syndrome and pulmonary edema.

6. Specialized Burn Pharmacology: Neuromuscular Junction Dynamics

Thermal injury alters the structure and density of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction, fundamentally altering neuromuscular blocker pharmacology. +---------------------------------------------------------------------------------------------------------+

  • | BURN NEUROMUSCULAR PHARMACOLOGY MATRIX |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Neuromuscular Agent | Post-Burn Time Window | Clinical Effect & Molecular Mechanism |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Succinylcholine** | **First 24 to 48 Hours Post-Burn** | • **SAFE to administer** |
  • | (Depolarizing) | | • Normal baseline potassium release (~0.5|
  • | | | mEq/L); receptors not yet upregulated |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Succinylcholine** | **> 24 - 48 Hours up to 1 - 2 Years**| • **STRICTLY CONTRAINDICATED (LETHAL!)** |
  • | (Depolarizing) | (or until fully healed/rehabilitated)| • Extrajunctional receptor upregulation |
  • | | | causes massive $K^+$ surge ($>8-10$) |
  • | | | → **Refractory VFib & Asystolic Arrest**|
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Non-Depolarizing** | **> 24 - 48 Hours Post-Burn** | • **MARKED RESISTANCE (Decreased Sens.)**|
  • | **NMBs (Rocuronium,** | | • Dose requirement is **2 to 3-fold** |
  • | **Vecuronium, Cis)** | | **higher**; shorter duration of action |
  • | | | • More receptors require more antagonist |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Pseudocholinester-**| Post-Burn Hospital Course | • **Decreased activity** (hepatic impair)|
  • | ** ase Enzyme** | | • Prolongs mivacurium & ester locals |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • Molecular Mechanism of Extrajunctional Receptor Proliferation

Starting 24 hours after a major thermal injury, the neuromuscular junction undergoes massive structural remodeling:

Receptor Proliferation: Fetal embryonic isoform ( α 1 β 1 γ δ \alpha_1\beta_1\gamma\delta α 1 ​ β 1 ​ γ δ ) and neuronal ( α 7 \alpha_7 α 7 ​ ) nicotinic acetylcholine receptors proliferate and spread across the entire skeletal muscle sarcolemma beyond the motor endplate.

Channel Kinetics: These immature extrajunctional receptors remain open longer when depolarized by succinylcholine, permitting massive, uncontrolled intracellular potassium ( K + K^+ K + ) efflux into systemic circulation.

Non-Depolarizer Competition: Because the total population of acetylcholine receptors across the muscle membrane is dramatically increased, significantly higher concentrations of competitive antagonists (Rocuronium, Vecuronium, Cisatracurium) are required to occupy ≥ 75 − 90 % \ge 75 - 90\% ≥ 75 − 90% of receptors to achieve surgical muscle relaxation.

Loading diagram... Airway Laser Fire, Trauma, and Burn Management Protocols